Indranil Debnath, MD
Otolaryngology · Winter Park, FLNPI 1649488735
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 61.3% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $35,901 and has fallen 93.9% since, to $2,172 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $431.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$67K
- Optinose US, Inc.$41K
- Regeneron Healthcare Solutions, Inc.$516
- Aerin Medical Inc.$231
- Acclarent, Inc$222
- Sanofi$191
- plus $555 from 11 others
What the payments were for
- Consulting fees$57,27552%
- Speaking & faculty fees$34,09531%
- Travel & lodging$12,15011%
- Food & beverage$5,6385%
- Education$1220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 103 | $66,995 |
| Optinose US, Inc. | 94 | $40,571 |
| Regeneron Healthcare Solutions, Inc. | 19 | $516 |
| Aerin Medical Inc. | 5 | $231 |
| Acclarent, Inc | 8 | $222 |
| Sanofi | 8 | $191 |
| Genentech USA, Inc. | 1 | $125 |
| Bard Access Systems, Inc. | 1 | $94 |
| Integra Lifesciences Corporation | 2 | $79 |
| Advanced Bionics, LLC | 2 | $74 |
| Inspire Medical Systems, Inc. | 3 | $58 |
| Alk-abello, Inc | 2 | $30 |
| Intersect ENT, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $22 |
| GSK | 1 | $22 |
| Novartis | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xhance$39,430
- XPRESS ENT DILATION SYSTEM$35,534
- SCOPIS ENT$27,944
- ENTELLUS - XPRESS ENT DILATION SYSTEM$25,072
- LATERA$20,804
- TGS GUIDEWIRE$17,107
- CLARIFIX CRYOTHERAPY DEVICE$13,335
- SHAVER SYSTEM$7,960
- ORTHOMAP$750
- ENTELLUS - ENTELLUS MEDICAL SHAVER SYSTEM$428
- ENTELLUS MEDICAL FOCESS SINUSCOPE$400
- HEMOPORE$400
- NASOPORE$400
- XEROGEL NASAL/EPISTAXIS 2 PACK$400
- VIVAER STYLUS$147
- RHINAER STYLUS$147
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$128
- XOLAIR$125
How this compares
$109,280 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 36 | $140,406 |
| XhanceFluticasone Propionate | 58 | $41,065 |
| Azelastine Hcl | 260 | $8,844 |
| Ipratropium Bromide | 164 | $4,575 |
| Fluticasone Propionate | 127 | $2,151 |
| Ofloxacin | 73 | $1,664 |
| Omeprazole | 106 | $1,619 |
| Levocetirizine Dihydrochloride | 48 | $921 |
| Famotidine | 60 | $877 |
| Fluocinolone Acetonide Oil | 18 | $854 |
| Prednisone | 62 | $706 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $588 |
| Doxycycline Hyclate | 33 | $335 |
| Mupirocin | 48 | $296 |
| Methylprednisolone | 47 | $273 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $40,571 | $41,06558 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 586 otolaryngology providers in Florida.
Other otolaryngology in Winter Park
- Hao TranWinter Park$18K
- Cecelia DamaskOrlando$707K
- Ralph TufanoSarasota$469K
- Franklin RimellFort Myers$314K
- David BrodnerBoynton Beach$209K
- Maria SuurnaMiami$189K
- Jane DillonOrmond Beach$180K
- Jeb JusticeGainesville$142K
- Agustin ArrietaMiami$95K
- John WestineGainesville$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.